Vitrolife AB (publ) (VTRLY)
USD 18.0
(7.46%)
USD 18.0
(7.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.66 Billion SEK | -3.75% |
| 2022 | 3.81 Billion SEK | -6.77% |
| 2021 | 4.08 Billion SEK | 1319.05% |
| 2020 | 288.07 Million SEK | -15.54% |
| 2019 | 341.05 Million SEK | 69.47% |
| 2018 | 201.25 Million SEK | 3.86% |
| 2017 | 193.77 Million SEK | -15.79% |
| 2016 | 230.1 Million SEK | 7.39% |
| 2015 | 214.27 Million SEK | -20.61% |
| 2014 | 269.91 Million SEK | 63.38% |
| 2013 | 165.2 Million SEK | -9.83% |
| 2012 | 183.21 Million SEK | 49.11% |
| 2011 | 122.87 Million SEK | 19.23% |
| 2010 | 103.05 Million SEK | 118.12% |
| 2009 | 47.24 Million SEK | -6.02% |
| 2008 | 50.27 Million SEK | 9.11% |
| 2007 | 46.07 Million SEK | -8.57% |
| 2006 | 50.39 Million SEK | 44.32% |
| 2005 | 34.92 Million SEK | -0.13% |
| 2004 | 34.96 Million SEK | -13.8% |
| 2003 | 40.56 Million SEK | -47.4% |
| 2002 | 77.11 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 3.74 Billion SEK | -0.27% |
| 2024 Q2 | 3.75 Billion SEK | 3.16% |
| 2024 Q1 | 3.64 Billion SEK | -0.76% |
| 2023 Q4 | 3.66 Billion SEK | -2.16% |
| 2023 Q2 | 3.96 Billion SEK | 5.92% |
| 2023 Q1 | 3.74 Billion SEK | -1.68% |
| 2023 FY | 3.66 Billion SEK | -3.75% |
| 2023 Q3 | 3.74 Billion SEK | -5.54% |
| 2022 Q3 | 3.8 Billion SEK | -2.88% |
| 2022 Q2 | 3.91 Billion SEK | -1.9% |
| 2022 Q4 | 3.81 Billion SEK | 0.18% |
| 2022 FY | 3.81 Billion SEK | -6.77% |
| 2022 Q1 | 3.99 Billion SEK | -2.32% |
| 2021 Q1 | 333.53 Million SEK | 15.78% |
| 2021 FY | 4.08 Billion SEK | 1319.05% |
| 2021 Q3 | 364.74 Million SEK | 0.54% |
| 2021 Q4 | 4.08 Billion SEK | 1020.76% |
| 2021 Q2 | 362.78 Million SEK | 8.77% |
| 2020 Q1 | 320.95 Million SEK | -5.89% |
| 2020 Q4 | 288.07 Million SEK | -2.22% |
| 2020 Q3 | 294.61 Million SEK | -6.66% |
| 2020 FY | 288.07 Million SEK | -15.54% |
| 2020 Q2 | 315.63 Million SEK | -1.66% |
| 2019 Q3 | 364.7 Million SEK | 4.4% |
| 2019 FY | 341.05 Million SEK | 69.47% |
| 2019 Q1 | 282.94 Million SEK | 40.59% |
| 2019 Q4 | 341.05 Million SEK | -6.48% |
| 2019 Q2 | 349.32 Million SEK | 23.46% |
| 2018 Q4 | 201.25 Million SEK | -3.41% |
| 2018 Q1 | 218.73 Million SEK | 12.88% |
| 2018 FY | 201.25 Million SEK | 3.86% |
| 2018 Q2 | 221.26 Million SEK | 1.16% |
| 2018 Q3 | 208.35 Million SEK | -5.83% |
| 2017 Q4 | 193.77 Million SEK | 9.78% |
| 2017 FY | 193.77 Million SEK | -15.79% |
| 2017 Q3 | 176.5 Million SEK | -17.31% |
| 2017 Q2 | 213.46 Million SEK | 2.01% |
| 2017 Q1 | 209.26 Million SEK | -9.06% |
| 2016 Q4 | 230.1 Million SEK | -1.29% |
| 2016 Q1 | 222.55 Million SEK | 3.87% |
| 2016 Q2 | 233.05 Million SEK | 4.72% |
| 2016 FY | 230.1 Million SEK | 7.39% |
| 2016 Q3 | 233.12 Million SEK | 0.03% |
| 2015 Q2 | 220.07 Million SEK | 0.67% |
| 2015 Q1 | 218.61 Million SEK | -19.0% |
| 2015 Q4 | 214.27 Million SEK | 11.5% |
| 2015 FY | 214.27 Million SEK | -20.61% |
| 2015 Q3 | 192.17 Million SEK | -12.68% |
| 2014 Q3 | 170.09 Million SEK | 4.99% |
| 2014 Q1 | 155.33 Million SEK | -5.98% |
| 2014 FY | 269.91 Million SEK | 63.38% |
| 2014 Q4 | 269.91 Million SEK | 58.68% |
| 2014 Q2 | 162 Million SEK | 4.3% |
| 2013 Q4 | 165.2 Million SEK | 1.69% |
| 2013 Q2 | 186.86 Million SEK | 3.84% |
| 2013 Q3 | 162.46 Million SEK | -13.06% |
| 2013 Q1 | 179.94 Million SEK | -1.78% |
| 2013 FY | 165.2 Million SEK | -9.83% |
| 2012 Q3 | 523.51 Million SEK | 262.32% |
| 2012 Q1 | 123.82 Million SEK | 0.77% |
| 2012 Q2 | 144.49 Million SEK | 16.69% |
| 2012 Q4 | 183.21 Million SEK | -65.0% |
| 2012 FY | 183.21 Million SEK | 49.11% |
| 2011 FY | 122.87 Million SEK | 19.23% |
| 2011 Q4 | 122.87 Million SEK | 0.09% |
| 2011 Q2 | 119.26 Million SEK | 7.51% |
| 2011 Q1 | 110.93 Million SEK | 7.64% |
| 2011 Q3 | 122.76 Million SEK | 2.94% |
| 2010 Q3 | 60.47 Million SEK | 5.86% |
| 2010 FY | 103.05 Million SEK | 118.12% |
| 2010 Q2 | 57.12 Million SEK | 0.0% |
| 2010 Q4 | 103.05 Million SEK | 70.41% |
| 2009 Q4 | 47.24 Million SEK | 0.0% |
| 2009 FY | 47.24 Million SEK | -6.02% |
| 2008 FY | 50.27 Million SEK | 9.11% |
| 2007 FY | 46.07 Million SEK | -8.57% |
| 2006 FY | 50.39 Million SEK | 44.32% |
| 2005 FY | 34.92 Million SEK | -0.13% |
| 2004 FY | 34.96 Million SEK | -13.8% |
| 2003 FY | 40.56 Million SEK | -47.4% |
| 2002 FY | 77.11 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| IR-Med Inc. | 634 Thousand USD | -578448.896% |
| Polarean Imaging plc | 2.58 Million USD | -142040.847% |
| Avitar, Inc. | 11.59 Million USD | -31538.32% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -541209.532% |
| CVR Medical Corp. | - USD | -Infinity% |
| AVITA Medical, Inc. | 19.86 Million USD | -18364.262% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -173082.247% |
| Össur hf. | 688.8 Million USD | -432.516% |
| Zecotek Photonics Inc. | 5.86 Million USD | -62402.066% |
| QHSLab, Inc. | 2.05 Million USD | -178213.691% |
| Wellstar International, Inc. | 55.99 Million USD | -6451.106% |
| Össur hf. | 688.8 Million USD | -432.516% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -22710.186% |
| Escalon Medical Corp. | 2.94 Million USD | -124308.863% |
| Aurora Spine Corporation | 6.65 Million USD | -55028.581% |
| BrainsWay Ltd. | 15.31 Million USD | -23851.939% |
| BioElectronics Corporation | 16.62 Million USD | -21966.069% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -60904.745% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -7901.252% |
| Vivos Inc. | 245 Thousand USD | -1497018.414% |
| MicroPort Scientific Corporation | 2.48 Billion USD | -47.523% |
| Kelyniam Global, Inc. | 1.01 Million USD | -362016.029% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -1330746.764% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -149626.019% |
| Nanomix Corporation | 14.81 Million USD | -24659.113% |
| Theraclion SA | 13.01 Million EUR | -28079.469% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -71481.947% |
| Positron Corporation | 2.02 Million USD | -180946.576% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -101193.228% |
| Lombard Medical, Inc. | 53.79 Million USD | -6718.604% |
| ALR Technologies Inc. | 24.5 Million USD | -14868.154% |
| Stratec SE | 271.97 Million USD | -1248.676% |
| Vycor Medical, Inc. | 4.31 Million USD | -84851.181% |
| Heart Tronics, Inc. | 1.09 Million USD | -334941.73% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -155403.721% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -66876.277% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -5491.975% |
| VMS Rehab Systems, Inc. | 201.36 USD | -1821612931.387% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -66895.434% |
| Ingen Technologies, Inc. | 5.7 Million USD | -64143.275% |
| Odyssey Group International, Inc. | 6.61 Million USD | -55377.227% |
| United American Healthcare Corporation | 119 Thousand USD | -3082252.941% |
| ECGI Holdings, Inc. | 11.94 Million USD | -30619.339% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -276942.623% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -253506.179% |
| Urologix, Inc. | 12.64 Million USD | -28909.807% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -67875.485% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -43142.198% |
| SS Innovations International, Inc. | 11.18 Million USD | -32705.353% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -698052.029% |
| Smith & Nephew plc | 4.76 Billion USD | 22.994% |
| NIOX Group Plc | 9.8 Million USD | -37320.553% |
| Fuse Medical, Inc. | 15.11 Million USD | -24175.21% |
| Broncus Holding Corporation | 10.43 Million USD | -35060.477% |
| Brain Scientific Inc. | 7.42 Million USD | -49291.341% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -10750.946% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -461817.613% |